We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Church & Dwight Co
CHD
$24B
| $17.7M | 0.02% |
160,405
+7,254
| +5% | +$776K |
|
527
Martin Marietta Materials
MLM
$32.7B
| $17.6M | 0.02% |
36,804
-25,822
| -41% | -$13.1M |
|
528
Supernus Pharmaceuticals
SUPN
$2.78B
| $17.6M | 0.02% |
543,913
+17,661
| +3% | +$626K |
|
529
CGI
GIB
$15.3B
| $17.4M | 0.02% |
174,553
+7,822
| +5% | +$858K |
|
530
State Street
STT
$52.2B
| $17.4M | 0.02% |
194,528
+5,430
| +3% | +$519K |
|
531
Celldex Therapeutics
CLDX
$3.52B
| $17.4M | 0.02% |
957,794
-132,379
| -12% | -$2.96M |
|
532
Spyre Therapeutics
SYRE
$9.18B
| $17.2M | 0.02% |
1,068,892
-23,232
| -2% | -$483K |
|
533
AerCap
AER
$23.6B
| $17.2M | 0.02% |
168,446
-3,597
| -2% | -$356K |
|
534
Best Buy
BBY
$17.5B
| $17.1M | 0.02% |
232,984
+11,950
| +5% | +$985K |
|
535
Novanta
NOVT
$6.32B
| $17M | 0.02% |
132,667
+5,063
| +4% | +$728K |
|
536
Vita Coco
COCO
$3.85B
| $16.9M | 0.02% |
+549,979
| New | +$19.6M |
|
537
Broadridge
BR
$19.3B
| $16.8M | 0.02% |
69,445
-10,154
| -13% | -$2.39M |
|
538
Viridian Therapeutics
VRDN
$2.59B
| $16.8M | 0.02% |
1,248,721
| – | – |
|
539
Williams-Sonoma
WSM
$28.9B
| $16.8M | 0.02% |
106,363
-10,945
| -9% | -$2.12M |
|
540
Chewy
CHWY
$9.15B
| $16.7M | 0.02% |
514,652
-1,347
| -0.3% | -$48.3K |
|
541
Portland General Electric
POR
$5.74B
| $16.6M | 0.02% |
371,521
+354,079
| +2,030% | +$15.2M |
|
542
Ascendis Pharma A/S
ASND
$16.8B
| $16.5M | 0.02% |
106,758
-37,441
| -26% | -$5.35M |
|
543
Ford
F
$55.1B
| $16.5M | 0.02% |
1,640,257
-163,687
| -9% | -$1.6M |
|
544
VICI Properties
VICI
$28.7B
| $16.4M | 0.02% |
504,044
-114,631
| -19% | -$3.53M |
|
545
Illumina
ILMN
$29.1B
| $16.3M | 0.02% |
204,040
-978,414
| -83% | -$106M |
|
546
L3Harris
LHX
$54.1B
| $16.3M | 0.02% |
77,644
+2,094
| +3% | +$439K |
|
547
Cboe Global Markets
CBOE
$30.4B
| $16.2M | 0.02% |
71,698
+193
| +0.3% | +$40K |
|
548
HP
HPQ
$26.8B
| $16.2M | 0.02% |
584,210
-193,972
| -25% | -$6.14M |
|
549
Jack Henry & Associates
JKHY
$10.8B
| $16.1M | 0.02% |
88,203
+29,469
| +50% | +$5.14M |
|
550
Suncor Energy
SU
$74.7B
| $16.1M | 0.02% |
415,317
+11,136
| +3% | +$425K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.